摘要
在全球化进程不断深入的大背景下,很多公共产品已经超越国界成为国际公共产品。2020年新冠疫情肆虐全球,使疫苗等国际公共产品成为国际社会关注的重点之一。国际公共产品是在全球范围内提供、使各国人民受益的公共产品,其分类角度不断丰富,需求逐渐增加,供给主体、供给模式以及供给资金来源日益多元。新冠疫情的发生给国际公共产品带来诸多冲击,疫苗等国际公共产品供给不足等问题尤其突出。认识国际公共产品呈现出的新特点、有效解决疫苗为代表的国际公共产品的均衡供给、提高供给效率十分重要。中国作为成功控制住疫情并最早研发、推广疫苗的大国,在后疫情时代承担了更多责任,展现大国担当,为世界范围内社会、经济秩序的恢复等做出了重要贡献。
With the continuous development of globalization,many public goods have become international public goods that transcend national boundaries.The COVID-19 outbreak in 2020 has put international public goods,especially vaccines,in the global spotlight.International public goods refer to the public goods provided on a global scale that can benefit people all over the world.The categories of international public goods are constantly increasing,and so are the demands,supply subjects,supply modes and supply sources.With the evolution of the world pattern,emerging countries have also become suppliers.However,the outbreak and continue of Covid-19 had brought many shocks on various aspects of international public goods.Particularly,the shortage of vaccine is very serious.Therefore,it is very important to figure out the new characteristics of IPG,to realize an equilibrium supply of vaccine and other IPGs and to enhance the supply efficiency.China,as a country which is very successful in containing the pandemic,has begun to actively undertake the responsibility of supplying IPG.This paper is to review the major literatures in this field,then discuss the related questions arising because of the pandemic.It will be a basis for further study on IPG and a theoretical guide for China to supply IPG and build a human community of a shared future.
出处
《亚太安全与海洋研究》
CSSCI
2021年第4期77-94,I0004,共19页
Asia-Pacific Security and Maritime Affairs
基金
北京外国语大学“双一流”建设“新冠疫情”应急研究专项项目(编号:SYL2020ZX022)。